DeCoste, R.; Amemiya, Y.; Nersesian, S.; Westhaver, L.; Lee, S.N.; Carter, M.D.; Sapp, H.L.; Stueck, A.E.; Arnason, T.; Boudreau, J.;
et al. PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology. J. Clin. Med. 2022, 11, 4241.
https://doi.org/10.3390/jcm11144241
AMA Style
DeCoste R, Amemiya Y, Nersesian S, Westhaver L, Lee SN, Carter MD, Sapp HL, Stueck AE, Arnason T, Boudreau J,
et al. PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology. Journal of Clinical Medicine. 2022; 11(14):4241.
https://doi.org/10.3390/jcm11144241
Chicago/Turabian Style
DeCoste, Ryan, Yutaka Amemiya, Sarah Nersesian, Lauren Westhaver, Stacey N. Lee, Michael D. Carter, Heidi L. Sapp, Ashley E. Stueck, Thomas Arnason, Jeanette Boudreau,
and et al. 2022. "PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology" Journal of Clinical Medicine 11, no. 14: 4241.
https://doi.org/10.3390/jcm11144241
APA Style
DeCoste, R., Amemiya, Y., Nersesian, S., Westhaver, L., Lee, S. N., Carter, M. D., Sapp, H. L., Stueck, A. E., Arnason, T., Boudreau, J., Seth, A., & Huang, W.-Y.
(2022). PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology. Journal of Clinical Medicine, 11(14), 4241.
https://doi.org/10.3390/jcm11144241